Published on

Clinical Toxicology — Salicylates

1. Overview

Salicylates are a group of compounds used for analgesic, anti-inflammatory, antiplatelet, gastrointestinal, and topical dermatologic purposes.

Aspirin (acetylsalicylic acid) is the most familiar member of this group. Other sources include methyl salicylate, bismuth subsalicylate, salsalate, and several topical preparations.

Salicylate poisoning is potentially life-threatening because it produces a combination of:

  • Stimulation of respiration, causing respiratory alkalosis.
  • Uncoupling of oxidative phosphorylation, causing cellular energy failure.
  • Increased production of organic acids, causing metabolic acidosis.
  • Fluid and electrolyte depletion.
  • Increased penetration of salicylate into the brain when blood pH falls.

The characteristic presentation includes nausea, vomiting, tinnitus, tachypnea, and mixed respiratory alkalosis with metabolic acidosis.

Severe poisoning can produce encephalopathy, seizures, hyperthermia, noncardiogenic pulmonary edema, shock, and death.

Acute and chronic salicylate poisoning must be assessed differently. Patients with chronic toxicity may develop serious neurologic and respiratory complications at concentrations that would be less concerning after an acute ingestion.

There is no specific molecular antidote.

The essential treatments are intravenous sodium bicarbonate, correction of fluid and potassium deficits, maintenance of respiratory alkalosis, and early hemodialysis when indicated.

2. Forms and sources

Aspirin

Aspirin is used for selected analgesic, anti-inflammatory, and antiplatelet indications.

Products may contain aspirin alone or in combination with acetaminophen, caffeine, opioids, or other medications.

Enteric-coated and modified-release preparations can cause delayed or prolonged absorption.

Bismuth subsalicylate

Bismuth subsalicylate is found in gastrointestinal medications, including Pepto-Bismol.

Repeated excessive dosing can cause chronic salicylate toxicity, particularly in older adults or patients with impaired kidney function.

Methyl salicylate

Methyl salicylate is present in:

  • Oil of wintergreen.
  • Medicated oils.
  • Some topical analgesic creams.
  • Liniments and muscle rubs.
  • Certain traditional or herbal preparations.

Concentrated methyl salicylate is especially dangerous to children.

Approximately 1 mL of concentrated oil of wintergreen is equivalent to 1.4 g of aspirin.

Consequently, a 5 mL teaspoon contains the aspirin-equivalent dose of approximately 7 g.

Topical salicylic acid

Wart removers and chemical-peeling products may contain concentrated salicylic acid.

Extensive application, damaged skin, prolonged contact, or occlusive dressings can increase systemic absorption.

Other preparations

Salsalate and certain other salicylate-containing medications may produce systemic salicylate toxicity.

The precise active ingredient, concentration, formulation, and route of exposure must be identified.

3. Toxic dose

Dose estimates are useful for initial triage but do not reliably predict the clinical course.

For acute aspirin ingestion, commonly used approximate risk categories are:

  • Less than 150 mg/kg: Significant toxicity is less likely after a reliably isolated ingestion.
  • 150–300 mg/kg: Potentially toxic; medical assessment is warranted.
  • 300–500 mg/kg: Risk of severe toxicity.
  • More than 500 mg/kg: Potentially life-threatening exposure.

These categories are not absolute boundaries.

Risk may be greater with chronic ingestion, methyl salicylate, impaired renal function, or delayed absorption.

Chronic exposure

Repeated excessive use over days or weeks can produce progressive toxicity.

Older patients are particularly vulnerable because nonspecific symptoms may initially be attributed to infection, dehydration, or other medical conditions.

A patient with chronic salicylate toxicity may be critically ill at a serum concentration of 40–50 mg/dL.

4. Pathophysiology

Respiratory stimulation

Salicylate directly stimulates the medullary respiratory center.

This causes increased respiratory rate and depth, lowering arterial carbon dioxide.

The resulting primary disturbance is respiratory alkalosis.

Uncoupling of oxidative phosphorylation

Salicylate interferes with mitochondrial energy production.

Cells consume oxygen while producing less usable ATP.

This generates heat and contributes to increased metabolic activity, hyperthermia, and cellular dysfunction.

Metabolic acidosis

Salicylate toxicity increases production of lactate, ketoacids, and other organic acids.

These processes contribute to an increased-anion-gap metabolic acidosis.

Mixed acid-base disorder

The characteristic adult presentation is simultaneous:

Primary respiratory alkalosis + increased-anion-gap metabolic acidosis.

Blood pH may initially be normal or alkalemic despite significant toxicity.

In children and severe late poisoning, metabolic acidosis may predominate.

Importance of blood pH

Salicylate is a weak acid.

As extracellular pH decreases, the proportion of nonionized salicylate increases.

This form crosses cell membranes and the blood–brain barrier more readily.

Acidemia increases tissue toxicity even when serum salicylate concentrations are falling.

5. Toxicokinetics

Aspirin is rapidly converted to salicylic acid.

At therapeutic concentrations, salicylate elimination involves hepatic metabolism and renal excretion.

Saturable metabolism

At high concentrations, hepatic metabolic pathways become saturated.

Elimination may shift toward capacity-limited kinetics, causing a disproportionate increase in circulating salicylate.

Delayed absorption

Large ingestions may cause delayed gastric emptying, pylorospasm, or formation of tablet aggregates.

Enteric-coated tablets can prolong absorption substantially.

Clinical implications

An initially low salicylate concentration does not exclude serious poisoning.

Some patients experience continued increases many hours after ingestion.

A single concentration must therefore never be used to establish that a substantial aspirin exposure is safe.

6. Clinical manifestations

Mild to moderate toxicity

Early findings may include:

  • Nausea and vomiting.
  • Epigastric discomfort.
  • Tinnitus.
  • Reduced hearing.
  • Sweating.
  • Tachycardia.
  • Tachypnea.
  • Dizziness and weakness.

Neurologic toxicity

Severe poisoning can cause agitation, confusion, delirium, seizures, cerebral edema, and coma.

Altered mental status is a major warning finding and an important indication for dialysis assessment.

Respiratory toxicity

Hyperventilation is an early characteristic finding.

Severe poisoning may cause noncardiogenic pulmonary edema and hypoxemic respiratory failure.

A falling respiratory rate in a deteriorating patient may indicate exhaustion or failure of respiratory compensation.

Cardiovascular toxicity

Patients may develop profound volume depletion, hypotension, shock, and secondary dysrhythmias.

Metabolic abnormalities

Hypokalemia is common.

Hyperglycemia or hypoglycemia may occur.

Importantly, the brain may develop inadequate glucose availability even when serum glucose is within the normal range.

Hyperthermia

Elevated temperature reflects increased metabolic heat production.

Significant hyperthermia is associated with severe poisoning and increased metabolic demand.

Renal complications

Acute kidney injury can result from dehydration, reduced renal perfusion, or severe systemic toxicity.

Renal dysfunction also reduces salicylate elimination.

7. Chronic salicylate poisoning

Chronic poisoning is particularly easy to miss.

Patients may present with several days of:

  • Confusion or altered behavior.
  • Weakness.
  • Recurrent vomiting.
  • Tachypnea.
  • Dehydration.
  • Unexplained metabolic abnormalities.
  • Worsening kidney function.

Tinnitus may be absent or not reported.

Older adults

An older patient taking repeated doses for pain may develop severe poisoning without a recognizable single overdose.

The presentation may resemble sepsis, pneumonia, heart failure, stroke, or another metabolic encephalopathy.

Clinical principle

Do not require a high serum concentration or a history of intentional overdose before considering salicylate poisoning.

In chronic poisoning, clinical condition is more important than applying thresholds developed for acute ingestion.

8. Diagnosis

Exposure history

Determine the product, strength, amount, timing, and route.

Ask about enteric-coated aspirin, bismuth subsalicylate, topical products, and medicated oils.

Identify underlying kidney disease, pregnancy, fluid depletion, and coingestants.

Serial salicylate concentrations

Obtain an initial serum salicylate concentration promptly when significant toxicity is possible.

Repeat concentrations approximately every two hours initially when absorption may be continuing or the clinical course is uncertain.

Testing intervals can be adjusted as the trend becomes clear.

Continue until concentrations are convincingly declining, the patient is clinically improving, and acid-base abnormalities are resolving.

Interpreting concentrations

Concentrations are commonly reported in mg/dL.

For conversion:

1 mmol/L salicylate ≈ 13.8 mg/dL.

The number must be interpreted alongside:

  • Acute versus chronic exposure.
  • Clinical findings.
  • Blood pH.
  • Kidney function.
  • Time since ingestion.
  • Serial concentration trends.

Blood gas analysis

A venous or arterial blood gas can assess pH and carbon dioxide.

Arterial sampling is particularly helpful when severe respiratory compromise or precise ventilation assessment is present.

Other laboratory tests

Obtain electrolytes, bicarbonate, glucose, creatinine, and anion gap.

Additional testing may include magnesium, calcium, lactate, liver tests, and coagulation studies, as clinically indicated.

Other investigations

An ECG and acetaminophen concentration are often appropriate after intentional or uncertain overdose.

Chest radiography may identify pulmonary edema.

Laboratory pitfall

At high concentrations, salicylate may interfere with some chloride-measuring electrodes, causing pseudohyperchloremia.

This can falsely reduce the calculated anion gap.

A normal or negative anion gap therefore does not reliably exclude severe salicylate poisoning when the clinical presentation is suggestive.

Done nomogram

The historical Done nomogram is not recommended for determining the severity of salicylate poisoning.

It cannot reliably account for delayed absorption, chronic exposure, altered protein binding, or changes in blood pH.

9. Initial treatment

Salicylate poisoning is a medical emergency when significant toxicity is suspected.

Contact a poison control center or medical toxicologist early.

Stabilization

Assess airway protection, respiratory effort, circulation, mental status, and temperature.

Obtain intravenous access, ECG monitoring, and frequent glucose measurements when indicated.

Fluids

Patients are often volume depleted from vomiting, sweating, and hyperventilation.

Correct fluid deficits with appropriately titrated intravenous crystalloid.

Avoid excessive fluids in patients with pulmonary edema, kidney dysfunction, or heart failure.

Glucose

Treat documented hypoglycemia promptly.

In patients with neurologic manifestations and suspected cerebral glucose depletion, dextrose may be considered even when blood glucose is not frankly low.

Potassium

Correct hypokalemia.

Potassium depletion makes it difficult to alkalinize urine and increases the risk of dysrhythmias.

The goal is generally to maintain potassium in the normal or upper-normal range while accounting for renal function.

10. Sodium bicarbonate therapy

Intravenous sodium bicarbonate is a principal treatment for significant salicylate poisoning.

It provides two benefits.

Serum alkalinization

Increasing extracellular pH reduces salicylate distribution into the central nervous system and other tissues.

Urinary alkalinization

An alkaline urinary environment reduces renal tubular reabsorption of salicylate.

This substantially enhances urinary elimination when kidney function is adequate.

Indications

Bicarbonate therapy is generally appropriate for clinically significant salicylate toxicity, particularly when there is metabolic acidosis, important symptoms, or elevated concentrations.

Do not wait for acidemia to develop before beginning treatment when significant toxicity is evident.

Administration

A commonly used hospital regimen is an intravenous sodium bicarbonate infusion containing approximately 150 mEq in one liter of 5% dextrose, with potassium supplementation when appropriate.

Some patients require an initial intravenous bicarbonate bolus.

Rates and supplementation must be individualized according to blood pH, electrolytes, urine pH, fluid balance, and renal function.

Treatment targets

Common targets are:

  • Urine pH: 7.5–8.0.
  • Blood pH: Maintain slight alkalemia, often approximately 7.45–7.55.
  • Potassium: Normal or upper-normal range.

Excessive alkalemia, hypokalemia, hypernatremia, and fluid overload must be avoided.

Monitoring

Check blood gases, electrolytes, salicylate concentrations, and clinical status repeatedly.

Urinary pH monitoring is useful during alkalinization.

Limitations

Bicarbonate treatment may be ineffective or difficult to administer in severe kidney dysfunction, pulmonary edema, or refractory circulatory failure.

In these circumstances, hemodialysis should be considered early rather than persisting with ineffective alkalinization.

11. Hemodialysis

Intermittent hemodialysis is the preferred extracorporeal treatment for severe salicylate poisoning.

It directly removes salicylate and simultaneously corrects important acid-base, fluid, and electrolyte abnormalities.

EXTRIP recommendations

The EXTRIP workgroup recommends extracorporeal treatment when any of the following are present:

  • Serum salicylate concentration greater than 100 mg/dL.
  • Concentration greater than 90 mg/dL with impaired kidney function.
  • Altered mental status.
  • New hypoxemia requiring supplemental oxygen.
  • Failure of standard treatment, including bicarbonate therapy.

EXTRIP also suggests extracorporeal treatment when:

  • Salicylate concentration is greater than 90 mg/dL, even without other indications.
  • Concentration is greater than 80 mg/dL with impaired kidney function.
  • Systemic pH is 7.20 or lower.

Chronic poisoning

These concentration criteria must not be treated as the only reasons for dialysis.

A chronically exposed patient with significant neurologic symptoms, pulmonary injury, or other severe manifestations may need dialysis at a serum concentration of approximately 40 mg/dL.

Other considerations

Seizures, severe hyperthermia, shock, progressive acidosis, rising concentrations despite treatment, and inability to administer adequate bicarbonate are additional reasons for urgent toxicology and nephrology assessment.

Timing

Do not delay dialysis preparation until the patient develops extreme acidemia or profound neurologic deterioration.

Continue appropriate bicarbonate treatment while arranging dialysis, unless contraindicated.

Stopping dialysis

EXTRIP recommends that dialysis cessation be guided by clinical improvement together with a salicylate concentration below approximately 19 mg/dL, or by its alternative criteria when timely concentrations are unavailable.

Subsequent monitoring may be required to detect a rebound in concentration.

12. Intubation and mechanical ventilation

This is one of the most dangerous parts of salicylate management.

Why intubation is hazardous

A patient with salicylate poisoning may maintain an extremely low carbon dioxide concentration through vigorous spontaneous hyperventilation.

Sedation and paralysis can abruptly reduce minute ventilation.

Carbon dioxide then rises, blood pH falls, and salicylate moves more readily into the brain.

This may precipitate seizures, cerebral edema, cardiovascular collapse, or death.

Clinical recommendation

Avoid intubation solely because the patient is hyperventilating.

Hyperventilation may be essential compensation for the metabolic disturbance.

When intubation is necessary

Intubation may be unavoidable in respiratory failure, profound encephalopathy, uncontrolled seizures, or inability to protect the airway.

Critical precautions

An experienced resuscitation team should minimize interruption of ventilation.

Intravenous bicarbonate may be appropriate around the procedure.

After intubation, mechanical ventilation must preserve the patient’s high minute ventilation and appropriately low carbon dioxide concentration.

Do not normalize PaCO₂ to 40 mm Hg simply because the patient is receiving mechanical ventilation.

Frequent blood gas measurements are essential.

When possible, dialysis should be arranged before substantial deterioration makes airway intervention unavoidable.

13. Gastrointestinal decontamination

Induced vomiting

Do not induce vomiting.

Ipecac is obsolete and can delay more effective treatment.

Gastric lavage

Routine gastric lavage is not recommended.

Activated charcoal

A single dose may be considered after a significant recent ingestion, provided the airway is protected.

Delayed absorption from large or enteric-coated aspirin ingestions may make charcoal useful beyond the usual early treatment window in selected patients.

Multiple-dose charcoal

Repeated charcoal has been used when substantial ongoing gastrointestinal absorption is suspected.

However, evidence that it improves meaningful clinical outcomes is limited.

It should not be applied as a universal regimen.

Whole-bowel irrigation

Whole-bowel irrigation may be considered in rare, selected cases involving very large modified-release or enteric-coated aspirin ingestions with evidence of continued absorption.

It is not recommended routinely.

It carries risks of vomiting, aspiration, and fluid-management complications and must never delay bicarbonate treatment or dialysis.

14. Pregnancy and lactation

Pregnancy

The former FDA pregnancy letter categories are obsolete.

Low-dose aspirin, commonly 81 mg daily, may be indicated during pregnancy, including for prevention of preeclampsia in selected patients.

This is distinct from high-dose aspirin used for analgesic or anti-inflammatory effects.

The FDA advises avoiding most NSAIDs at approximately 20 weeks of pregnancy or later unless clinically necessary, with particular concern about fetal renal dysfunction and low amniotic fluid.

The recommendation specifically exempts appropriately prescribed low-dose aspirin.

Salicylate poisoning during pregnancy

Significant maternal toxicity can threaten the fetus through maternal acid-base disturbances, impaired oxygen delivery, and placental transfer of salicylate.

Treatment priorities remain maternal resuscitation, appropriate alkalinization, and timely dialysis when indicated.

Obstetric consultation is appropriate.

Breastfeeding

Low-dose aspirin results in low salicylate exposure through breast milk.

However, regular high-dose aspirin is not preferred during breastfeeding because exposure rises disproportionately with increasing maternal dose.

Alternative analgesics are generally preferable when prolonged treatment is required.

15. Observation and disposition

Minor accidental ingestion

A reliably small isolated ingestion may not require hospital evaluation if a poison center determines that the exposure is low risk.

Potentially toxic ingestion

Patients with an estimated acute aspirin exposure of approximately 150 mg/kg or greater generally warrant medical assessment.

A small-volume ingestion of concentrated methyl salicylate may warrant urgent evaluation at much lower apparent volumes.

Emergency department discharge

Discharge should not be based solely on a fixed four- or six-hour observation period.

A patient may be considered for discharge only when:

  • Symptoms are absent or resolved.
  • Acid-base status is reassuring.
  • Serial salicylate concentrations show a convincing decline.
  • Further absorption is unlikely.
  • Renal function and clinical findings are appropriate for outpatient care.
  • Necessary follow-up is arranged.

Hospital admission

Admission is appropriate for symptomatic poisoning, elevated or rising concentrations requiring treatment, acid-base abnormalities, electrolyte disturbances, or significant underlying medical risk.

Intensive care

ICU treatment is warranted for severe neurologic symptoms, pulmonary edema, major acid-base disturbance, shock, respiratory failure, or anticipated hemodialysis in an unstable patient.

Chronic poisoning

Patients with chronic salicylate toxicity often require admission because delayed recognition and significant underlying illness increase the risk of deterioration.

16. Expected course and prognosis

Mild acute poisoning generally resolves with timely supportive care.

Moderate toxicity may require intravenous bicarbonate and monitoring over one or more days.

Severe toxicity can progress rapidly and may be fatal without dialysis.

Chronic poisoning is associated with substantial morbidity because patients may present late with encephalopathy, pulmonary complications, and impaired kidney function.

Persistent neurologic injury can follow severe cerebral toxicity, prolonged hypoxemia, or other complications.

Early diagnosis, correction of acid-base disturbances, and timely hemodialysis are the principal factors clinicians can modify to improve outcomes.

17. Prevention and patient education

Avoid giving aspirin to children or adolescents with viral illnesses unless specifically prescribed for an established indication, because of the association with Reye syndrome.

Store aspirin and methyl salicylate products securely.

Do not use concentrated oil of wintergreen as an oral home remedy.

Avoid excessive topical salicylate application, especially under occlusive dressings or on damaged skin.

Check combination cold, pain, and gastrointestinal medications for salicylate-containing ingredients.

Older adults taking repeated doses of aspirin or bismuth subsalicylate should be assessed for cumulative exposure and kidney function.

Patients using prescribed low-dose aspirin should not discontinue it without considering the underlying cardiovascular or obstetric indication.

18. Clinical pitfalls

Relying on a single salicylate concentration. Delayed absorption may cause the concentration to rise many hours after ingestion.

Assuming a declining concentration guarantees improvement. Falling pH can increase tissue toxicity despite lower blood concentrations.

Treating chronic poisoning like acute overdose. Severe chronic toxicity may occur at much lower concentrations.

Mistaking hyperventilation for anxiety. It may be the earliest sign of significant salicylate poisoning.

Assuming a normal blood pH excludes toxicity. Mixed respiratory alkalosis and metabolic acidosis may produce an apparently normal pH.

Missing pseudohyperchloremia. Laboratory interference may obscure the expected increased anion gap.

Underestimating methyl salicylate. One teaspoon of concentrated oil of wintergreen contains approximately 7 g of aspirin equivalents.

Correcting respiratory alkalosis during ventilation. Loss of compensatory hyperventilation can rapidly worsen CNS toxicity.

Failing to replace potassium. Hypokalemia prevents effective urinary alkalinization.

Waiting for extreme serum concentrations before considering dialysis. Altered mental status, hypoxemia, or failure of standard treatment can justify dialysis at lower concentrations.

Using the Done nomogram. It is not recommended for contemporary management.

Giving acetazolamide to alkalinize urine. It can worsen systemic acidosis and increase CNS salicylate penetration.

Using routine ipecac, lavage, or whole-bowel irrigation. These interventions do not have an established routine role.

Applying a universal six-hour discharge rule. Clinical recovery, acid-base status, and serial levels are more important.

Failing to distinguish low-dose aspirin in pregnancy from high-dose aspirin exposure. Their indications and safety considerations differ.


Key clinical conclusions

Salicylate poisoning is a dynamic metabolic emergency in which the patient’s clinical condition and acid-base status are at least as important as the serum salicylate concentration.

Aspirin overdose typically causes respiratory alkalosis combined with metabolic acidosis. Chronic poisoning may produce severe encephalopathy or pulmonary injury at relatively modest concentrations.

Intravenous sodium bicarbonate, potassium replacement, and careful fluid management are fundamental treatments.

Intermittent hemodialysis is the preferred treatment for severe poisoning, especially when there is neurologic toxicity, new hypoxemia, failure of standard treatment, severe acidemia, or concentrations meeting EXTRIP thresholds.

Intubation should be avoided when possible because interruption of compensatory hyperventilation can cause catastrophic acidemia.

The most important preventive lesson is to recognize all sources of salicylates, particularly concentrated methyl salicylate oils, delayed-release aspirin, and repeated use of over-the-counter products.


Image description
0 Comments